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AbstrACt 
Introduction The European population is rapidly 
ageing. In order to handle substantial future challenges 
in the healthcare system, we need to shift focus from 
treatment towards health promotion. The PreventIT project 
has adapted the Lifestyle-integrated Exercise (LiFE) 
programme and developed an intervention for healthy 
young older adults at risk of accelerated functional decline. 
The intervention targets balance, muscle strength and 
physical activity, and is delivered either via a smartphone 
application (enhanced LiFE, eLiFE) or by use of paper 
manuals (adapted LiFE, aLiFE).
Methods and analysis The PreventIT study is a 
multicentre, three-armed feasibility randomised controlled 
trial, comparing eLiFE and aLiFE against a control group 
that receives international guidelines of physical activity. It 
is performed in three European cities in Norway, Germany, 
and The Netherlands. The primary objective is to assess 
the feasibility and usability of the interventions, and to 
assess changes in daily life function as measured by the 
Late-Life Function and Disability Instrument scale and 
a physical behaviour complexity metric. Participants are 
assessed at baseline, after the 6 months intervention 
period and at 1 year after randomisation. Men and women 
between 61 and 70 years of age are randomly drawn 
from regional registries and respondents screened for 
risk of functional decline to recruit and randomise 180 
participants (60 participants per study arm).
Ethics and dissemination Ethical approval was received 
at all three trial sites. Baseline results are intended to be 
published by late 2018, with inal study indings expected 
in early 2019. Subgroup and further in-depth analyses will 
subsequently be published.
trial registration number NCT03065088; Pre-results. 
bACkground  
The European population is rapidly ageing. 
Average life expectancy has exceeded 80 years 
across Organisation for Economic Co-oper-
ation and Development countries,1 with a 
concomitant increase in projected years spent 
with disabilities.2 In order to tackle future 
challenges on already overstretched health-
care systems, it is generally recognised that 
there needs to be shift of focus from treat-
ment towards promoting active and healthy 
ageing and prevention of age-related diseases 
and functional decline.3 
It is well documented that physical activity 
(PA) improves health and physical function 
and reduces disability at old age.4 Increasing 
PA4 as well as balance5 and strength5 training 
have been described as determinants for main-
taining function and ability. According to the 
WHO, physical inactivity is the fourth leading 
risk factor contributing to death worldwide 
strengths and limitations of this study
 Ź Adapted LiFE integrates individualised and appro-
priately challenging balance, muscle strength and 
physical activities into daily lives of young older 
adults.
 Ź Enhanced LiFE uses a smartphone/smartwatch 
app to offer a personalised lifestyle-integrated ac-
tivity programme, based on a risk screening of fu-
ture functional decline and an individual’s physical 
performance.
 Ź Technology-supported exercise programme allows 
participants to monitor their behaviour and receive 
messages and feedback in real time aiming to 
change their physical behaviour.
 Ź The 12-month follow-up enables monitoring and 
evaluation of long-term adherence to smart-
phone-based and paper-based interventions.
 Ź Potential sources of bias include the selection of 
participants and loss to follow-up if those who com-
plete the full data collection protocol are systemati-
cally different between the three groups.
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and increases the risk of adverse health outcomes, such 
as shortened life expectancy, cardiovascular disease, 
diabetes and cancer.6 Older adults are at increased risk of 
physical inactivity, with significant decline in activity levels 
occurring around the time of retirement.7 Simultane-
ously, this period of life provides the opportunity to adopt 
a healthy and active lifestyle, as there is still potential to 
prevent decline and maintain physical function required 
to remain active and independent in later life.8
In order to shift from an inactive to an active lifestyle, 
behaviour change is needed. However, uptake of and 
adherence to PA interventions is a challenge, as shown, for 
example, in fall prevention9 and evidence-based strength 
and balance programmes in older adults.10 Previous 
studies demonstrated that high intervention adherence 
rates can achieve statistically significant and clinically rele-
vant treatment effects.11 However, participants’ activity 
levels often revert back to previous low activity levels at 
the end of the intervention period,12 13 indicating that 
interventions must be supported by behavioural change, 
be acceptable and be based on theoretical and empiri-
cally tested principles.12 14 15
The PreventIT project (Early risk detection and preven-
tion in ageing people by self-administered ICT-supported 
assessment and a behavioural change intervention, deliv-
ered by use of smartphones and smartwatches) is a Euro-
pean Horizon 2020 Information and Communication 
Technology (ICT) and personal health project. The aim 
is to develop and test a personalised behaviour change 
intervention on PA aimed at young older adults that has 
the potential to prevent accelerated functional decline at 
older age.16
PreventIT is based on the Lifestyle-integrated Exer-
cise (LiFE) programme developed by Clemson et al.17 In 
LiFE, balance and muscle strengthening activities are 
embedded within everyday activities. Rather than using a 
prescribed set of exercises, LiFE activities occur whenever 
the opportunity for such activity arises during the day. 
The original LiFE programme was developed for adults 
70 years and older and tested in older home-dwelling 
people. It was found to significantly reduce falls, improve 
physical function, decrease disability and improve adher-
ence, compared with a traditional exercise programme 
and a sham intervention.18 Thus, tailoring exercise at an 
individual level and integrating it in daily life seems to be 
a promising approach.
In accordance with the UK Medical Research Council 
guidance19 on development, evaluation and imple-
mentation of complex interventions, the original LiFE 
programme was customised to the needs of a younger 
target group. The PreventIT consortium adapted 
and piloted the LiFE activities in order to make them 
adequately challenging, complex and meaningful for 
a younger target population (adapted LiFE, aLiFE) 
(paper submitted).20 21 In addition, the consortium 
further developed the behavioural change elements 
of the intervention,22 mapping these to behaviour 
change theory and techniques (table 1).23 Iterative 
stages of feasibility testing and evaluation of the aLiFE 
programme were applied including a proof of concept 
pilot study (ISRCTN37750605; https:// doi. org/ 10. 1186/ 
ISRCTN37750605). Subsequently, the aLiFE programme 
was transferred to a mobile health application system 
(PreventIT mHealth system),24 called enhanced LiFE 
(eLiFE) programme, delivering the intervention on smart-
phones and smartwatches.
In order to assess feasibility and usability, evaluate and 
further improve the intervention, and to suggest sample 
size and design for a future phase III clinical trial, this 
feasibility study is currently being conducted, comparing 
eLiFE and aLiFE interventions with a control group.
Aims
The aim of the multicentre randomised controlled feasi-
bility trial is to assess the feasibility of eLiFE and aLiFE 
programmes, integrating activities into daily life, versus a 
control group, targeting young older adults between 61 
and 70 years. There are five main research questions: (1) 
Participation: What are the levels of adherence of young 
older adults to specific activities and to the entire eLiFE 
and aLiFE intervention over the course of the study 
period? (2) Technology: What is the acceptability of the 
eLiFE intervention delivered using technology (smart-
phones and smartwatches) including user interface, 
goal setting, feedback, motivational messages and social 
interaction? (3) Feasibility and usability: What is the feasi-
bility of the eLiFE and aLiFE intervention programmes 
in a cohort of young older adults: What are the possible 
harms (adverse events) of the eLiFE or aLiFE interven-
tion? What is the acceptability of eLiFE and aLiFE activ-
ities (usefulness, safety, difficulty level, adaptability/
personalisation, planning and uptake of exercises)? Are 
the randomised controlled trial (RCT) methods suit-
able (recruitment, randomisation, follow-up, outcomes, 
and so on)? (4) Estimates of change: What is the change in 
function, as measured by two primary clinical outcome 
measures: the Late-Life Function and Disability Instru-
ment (LLFDI) and the behavioural complexity metric, 
for the eLiFE and the aLiFE interventions compared with 
the control group? What are the estimated effect sizes 
for LLFDI, complexity metric and the secondary clinical 
outcome measures? (5) Health economics evaluation: Is it 
feasible to collect data in order to estimate healthcare 
resource utilisation, costs and quality-adjusted life-years 
(QALY), and model incremental cost-effectiveness ratios 
(ICER) of aLiFE and eLiFE compared with the control 
group over a 6-month and 12-month time period?
MEthods
trial design
The study uses a three-arm RCT design, performed at 
three clinical sites including a total of 180 participants (60 
participants at each site; 20 participants in each arm per 
site). Inclusion of participants started in March 2017 with 
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Table 1 Behaviour change techniques adopted within aLiFE and eLiFE
Behaviour change techniques* aLiFE content eLiFE content
1. Goals and planning
  1.1 Goal setting (behaviour—which 
activities, where and how often)
Daily routine chart, activity planner App content (planning screens), instructor
  1.2 Problem solving Manual, instructor App content, instructor
  1.3 Goal setting (outcome—long term) Paper form, instructor App content (planning screens), instructor
  1.4 Action planning Activity planner, instructor App content (planning screens), instructor
  1.5 Review behavioural goals Activity planner, activity counter App content (daily reporting)
  1.6 Discrepancy between current 
behaviour and goal
Paper form, activity planner App content (motivational messaging, 
activity reporting)
  1.7 Review outcome goals Paper form, activity planner, activity 
counter, instructor
App content (motivational messaging, 
activity reporting)
2. Feedback and monitoring
  2.2 Feedback on behaviour Instructor App content (real-time feedback)
  2.3 Self-monitoring of behaviour Activity planner, activity counter App content (activity reporting)
  2.4 Self-monitoring of outcomes of 
behaviour
Activity planner, activity counter App content (motivational messaging)
  2.6 Biofeedback Not included System components (accelerometer) and 
app content (feedback screens)
  2.7 Feedback on outcomes of behaviour Instructor App content (real-time feedback)
3. Social support
  3.1 Social support Instructor App content (motivational messaging)
4. Shaping knowledge
  4.1 Instruction on how to perform the 
behaviour
Manual, instructor App content (text, pictures, videos)
5. Natural consequences
  5.1 Information about health 
consequences
Manual App content (motivational messaging)
  5.3 Information about social and 
environmental consequences
Manual App content (motivational messaging)
6. Comparison of behaviour
  6.1 Demonstrate the behaviour Manual (text, pictures), instructor App content (text, pictures, videos)
  6.2 Social comparison Not included App content (motivational messaging)
  6.3 Information about others’ approval Not included App content (motivational messaging)
7. Associations
  7.1 Prompts/cues Manual, instructor App content (planning screens)
8. Repetition and substitution
  8.1 Behavioural practice/rehearsal Manual, instructor App content (planning screens, real-time 
feedback, motivational messaging)
  8.3 Habit formation Manual, instructor, activity planner, 
activity counter
App content (planning screens, real-time 
feedback, motivational messaging)
  8.6 Generalisation of a target behaviour Manual, instructor, daily routine 
chart, activity planner
App content (motivational messaging)
  8.7 Graded tasks Manual, instructor App content (planning screens, real-time 
feedback, motivational messaging)
10. Reward and threat
  10.10 Reward (outcome) Instructor App content (real-time feedback, 
motivational messaging)
Continued
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a 6-month intervention period and 12-month follow-up 
from baseline lasting until August 2018.
study setting and test procedures
The three participating study sites are Trondheim, 
Norway; Amsterdam, The Netherlands; and Stuttgart, 
Germany. Telephone screening, risk screening, medical 
assessment as well as three on-site assessments (T1, T2, 
T3) are undertaken in university facilities (Norwegian 
University of Science and Technology (NTNU) Trond-
heim and Vrije Universiteit Amsterdam) and academic 
hospital (Robert Bosch Krankenhaus, Stuttgart). All other 
participant contact is through home visits or telephone 
communication. Participants are assessed at baseline (T1) 
within 6 weeks of initial screening, post-test (T2) 182 days 
after the first home visit (±2 weeks) and follow-up after 12 
months (T3) (364 days±4 weeks after the first home visit). 
Trained assessors (blinded to group allocation) perform 
all assessments at the collaborating centres. Each assess-
ment lasts approximately 1.5–2.5 hours.
Eligibility criteria
Persons born between 1 January 1947 and 31 December 
1956 (61–70 years of age at start of recruitment) were 
invited to participate via mail. Persons within the target 
group were randomly selected from three local popu-
lation registries (the National Registry in Norway, the 
Municipality Registry of Amsterdam and the Stuttgart 
Registry in Germany). The inclusion and exclusion 
criteria are presented in table 2. Eligibility for participa-
tion is determined through a telephone interview, a risk 
screening for functional decline and a medical screening. 
Rates of eligibility at each stage of the inclusion process 
are monitored.
sample size and recruitment
No sample size calculation was performed for this study 
as it is a feasibility study not designed to conclude on 
effectiveness. However, based on a Norwegian popula-
tion-based study,25 the sample size (n=180) is estimated to 
be large enough to estimate critical parameters,26 which 
equals twice the minimum required number of partici-
pants suggested (2× n=90) as a general rule to estimate a 
parameter.27 28
Participants are drawn from the general population 
with the purpose of identifying those estimated to be 
at risk of accelerated functional decline. The number 
required to invite in order to reach 180 participants is 
not predefined, due to insufficient knowledge about 
ability/function in this age group and because the risk 
screening tools (see below) are newly developed.16 A 
contact list was provided for home-dwelling individ-
uals between 61 and 70 years of age living in Trond-
heim, Amsterdam and Stuttgart, stratified by age and 
with even distribution of men and women in each age 
stratum. The initial draw from each local registry was 
set at 2000 persons, with the intention of performing 
a second draw if necessary.
screening
We recruited persons who actively replied to their respec-
tive study site by telephone or email following the mailing 
and invited them to undergo a multistep screening. 
Screening started with a structured telephone interview to 
determine interest and eligibility, which among other 
criteria included being retired and currently not under-
taking more than 150 min of moderate/vigorous PA per 
week (table 2). Eligible participants are then invited to an 
on-site risk screening and medical assessment (table 2). 
All participants sign an informed consent form prior to 
commencing the on-site assessments.
An online web-based tool developed through the 
PreventIT project (the PreventIT risk screening tool) 
is used to identify participants’ risk for functional 
decline.16 This is a newly developed tool, where the 
risk for functional decline over the next 9 years is 
estimated and participants are classified as being 
at ‘low risk’, ‘medium risk’ or ‘high risk’. At time of 
commencing recruitment, the tool had not yet been 
Behaviour change techniques* aLiFE content eLiFE content
  10.3 Non-speciic reward Instructor App content (real-time feedback, 
motivational messaging)
12. Antecedents
  12.1 Restructuring the physical 
environment
Manual, instructor App content (planning screens, motivational 
messaging)
  12.2 Restructuring the social 
environment
Manual, instructor App content (planning screens, motivational 
messaging)
15. Self-belief
  15.1 Verbal persuasion about capability Not included App content (motivational messaging)
  15.3 Focus on past success Not included App content (motivational messaging)
*Using Michie et al.23
aLiFE, adapted LiFE; eLiFE, enhanced LiFE.
Table 1 Continued 
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validated. Initially, only participants identified as 
being at ‘medium risk’ were to be included in the 
study, as prior analyses in other cohort data indicated 
that this would be a third of potential participants.16 
The telephone screening, which preceded on-site 
screening and assessment, was designed to exclude 
the majority of ‘low risk’ participants. Subsequently 
applying the risk screening tool on the selected sample 
showed that only about 10% of individuals invited 
for face-to-face assessment are classified as ‘medium 
risk’ and hence eligible for inclusion. Therefore, the 
selection of participants based on the risk screening 
tool was discontinued and the risk screening tool is 
now applied to estimate and describe the participants’ 
specific risk for functional decline within the recruited 
cohort. Participants who complete the face-to-face 
risk screening and are not excluded due to cognitive 
impairment (Montreal Cognitive Assessment >24)29 
Table 2 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Telephone 
screening
Between 61 and 70 years of age Current participation in an organised exercise class >1 per week
Retired (more than 6 months, <50% paid/
unpaid work)
Moderate-intensity physical activity ≥150 min/week in the previous 
3 months
Community dwelling Travels >2 months planned during intervention period
Able to read a newspaper or text on a 
smartphone
Speaks Norwegian/Dutch/German
Able to walk 500 m without walking aid
Available for home visits the following 
6 weeks
Risk 
screening
‘At risk’ for functional decline Cognitive impairment (Montreal Cognitive Assessment (MoCA) 
<24 points)
Acute depression
(STU and AMS)
Medical 
screening
Medical condition (heart failure New York Heart Association (NYHA) 
class III and IV)
Acute myocardial infarction last 6 months or unstable angina
Pericarditis, myocarditis, endocarditis in the last 6 months
Symptomatic aortic stenosis; cardiomyopathy
Resting blood pressures of a systolic >180 mm Hg or diastolic 
>100 mm Hg or higher
Chronic obstructive pulmonary disease (COPD) Gold class III and IV
Uncontrolled asthma at least two exacerbations in the last 6 months
Amputated lower extremities
Active cancer treatment during the last 6 months
Ankylosing spondylitis
History of schizophrenia
Parkinson’s disease
Cerebrovascular accident last 6 months
Epilepsy treated with medication
Severe rheumatoid arthritis (RA) interfering with mobility
Fracture of lumbar spinal vertebra/thoracic spinal vertebra or lower 
extremity in the last 6 months
Three fractures in the last 2 years due to severe osteoporosis
Acute depression (TRD)
After 
screening 
process
Spouse/living together with an already included participant in this trial
AMS, clinical site Amsterdam; STU, clinical site Stuttgart; TRD, clinical site Trondheim.
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are invited to a medical screening to ensure participa-
tion in an exercise intervention is not contraindicated. 
When all inclusion criteria are met, participants are 
invited to perform a full baseline assessment (T1).
data collection and outcome measures
All eligible participants undergo a phone screening, risk 
screening, medical screening and three measurements: 
one at entry into the study (baseline assessment, T1), 
one after the 6-month intervention period (T2) and one 
after completing the 6 months passive follow-up period 
(12 months assessment, T3). Table 3 highlights the 
measures collected, table 4 provides a summary of the 
schedule of enrolment, interventions and assessments, 
and table 5 provides an overview of intervention time 
frame.
blinding
All preintervention measures are assessed by trained 
research staff and the medical screening by medically 
qualified members of the research teams at the respective 
sites prior to randomisation. Postintervention measures 
are collected by personnel blinded to group allocation. 
Due to the nature of the intervention, it is not possible 
to blind participants or the instructors delivering the 
intervention. Outcome measures that identify group allo-
cation (eg, technology acceptability questionnaires) are 
collected by unblinded research staff.
outcome measures
All outcome measures are listed in table 3 and include 
sociodemographic data, outcomes regarding general 
health and function, medical history, medication use, 
neuropsychological assessments, measures of physical 
ability and quality of life measures. Further data are 
collected for economic evaluation purposes. During the 
12-month follow-up period monthly adherence rates are 
monitored and detailed information about adherence to 
the interventions is collected during the 6-month (T2) 
and 12-month (T3) assessments. Experience with the 
programme, motivation and behaviour change outcome 
measures, as well as outcome measures regarding willing-
ness to participate, usability of technology and accept-
ability of the intervention are collected after the active 
(first 6 months) and passive follow-up period (further 6 
months).
Among all outcome measures, two are the primary 
clinical outcomes that are related to change in function 
(objective 4) and measured using the LLFDI30 31 and a 
complexity metric,20 further developed and adapted within 
the project to assess behavioural complexity in the domains 
of PA, sleep and social participation.
The LLFDI was developed as a comprehensive question-
naire assessing function and disability for use in commu-
nity-dwelling older adults.30 31 The LLFDI contains items 
that represent functional limitations (inability to perform 
discreet physical tasks encountered in daily routines) and 
disability (inability to take part in major life tasks and 
social roles). The LLFDI assesses function in 32 PAs (in 
three dimensions: upper extremity, basic lower extremity 
and advanced lower extremity) and disability in 16 major 
life tasks.
PA and sleep data are collected via PA monitoring. After 
each measurement point (T1, T2, T3), participants’ PA 
is monitored for 7 consecutive days using activity moni-
tors at the lower back (fixed using adhesive tape) and the 
wrist (fixed in an elastic wristband) (AX3 sensors from 
Axivity; http:// axivity. com/ product/ ax3). Assessment 
on social interaction is based on detection of outdoor 
walking derived from the timing and the number of steps 
of walking episodes. Frequency and number of short 
message service and phone calls and Global Positioning 
System statistics are also used as possible social interac-
tion measures. These statistics are anonymous, without 
identifying the caller/sender. Data on physical behaviour 
are represented as time series embedding fundamental 
activity characteristics (ie, type, duration and intensity). 
The concept of complexity in physical behaviour postulates 
that high functional status is characterised by freedom 
of movement in terms of flexibility, ability to successfully 
achieve daily tasks, physical performance, diversity of activ-
ities and participation in social life. On the other hand, 
advanced ageing and age-related adverse events may be 
characterised by progressive movement impairment, 
difficulties with daily tasks and limitation of activities and 
social life, that is, less complex physical behaviour.32
As part of the on-site assessments, self-administered tests of 
mobility, balance and functional strength are used, where 
participants use a smartphone app to perform the ‘Timed 
Up and Go’,33 ‘Tandem stance, eyes open’ and ‘Five times 
sit-to-stand’ tests by following instructions in the app, 
with no additional guidance from the assessor. This test 
battery is developed as part of the PreventIT project, and 
the acceptance of self-administered tests will be evalu-
ated. The smartphone is worn in an elastic band around 
the participant’s waist during the self-administered tests, 
from which parameters such as sit-to-stand duration, jerk 
during sit-to-stand, mean step time, variability of step time 
and interstride trunk sway in anterior-posterior and medi-
olateral directions can be obtained.34 Participants also 
perform assessor-guided versions of the Timed Up and 
Go, Tandem stance (eyes open and closed), Five times 
sit-to-stand and the 30 s chair stand test originally from 
the Senior Fitness Test,35 during which the participant 
‘wears’ the smartphone to record movement parameters 
as during the self-administered tests.
randomisation
Randomisation is undertaken following 1 week of activity 
monitoring at baseline, using a web-based randomisa-
tion procedure developed, used and run by the Unit for 
Applied Clinical Research at the Faculty of Medicine and 
Health Sciences at NTNU. Randomisation is stratified to 
centre and performed by block randomisation, where 
block sizes can vary. One person at each site, unblinded 
to group allocation, has access to the web-based 
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Table 3 List of assessments and outcome measures collected during telephone screening, risk screening, medical screening, baseline assessment, after 6 months active 
intervention and further 6 months passive follow-up
TS RS MS T1 T2 T3 O
Sociodemographic
  Age, gender, employment status, living arrangements (community-dwelling or residential aged care facility), number of 
cohabitants, years of education
✓ –
  Economic satisfaction (good, suficient, bad/poor) ✓ –
  Prior experience with using smartphone technology (yes/no) ✓ –
General health and function
  Ability to walk 500 m without walking aid ✓ –
  Ability to read newspaper in print and on a smartphone ✓ – 
  Participation in an organised exercise group >1 per week (yes/no) ✓ ✓ ✓ S
  Currently undertaking 150 min or more in moderate-intensity PA per week (yes/no) ✓ ✓ ✓ S
  Amount of moderate-intensity PA undertaken per week (hardly active; mostly seated activities; light-intensity PA (2–4 hours/
week); moderate-intensity PA (1–2 hours/week) or light-intensity PA (>4 hours/week); moderate-intensity >3 hours/week; high-
intensity PA several times per week)
✓ ✓ ✓ S
  Late-Life Function and Disability Instrument (LLFDI) to assess meaningful change in function (person’s ability to do discrete 
actions/activities) and disability (person’s performance of socially deined tasks)30 31
✓ ✓ ✓ P
Medical history and medication use
  ‘Have you seen a doctor for being diagnosed for having problems with your joints?’* ✓ ✓ ✓ –
  ‘Have you seen a doctor for being diagnosed for having problems with your heart?’† ✓ ✓ ✓ –
  Medications used (total number, type, frequency, dosage) ✓ ✓ ✓ ✓ S
  Fall history (count over last 12 months) ✓ ✓ ✓ S
  Pain during rest and walking (numeric scale, score 0–10)41 ✓ ✓ ✓ S
  Blood pressure (mm Hg) in lying and standing (after 1 and 3 min); pulse, vision, hearing ✓ –
  Comorbidities (number, type, date of diagnosis and treatment) ✓ –
  Height (cm), weight (kg) ✓ –
  Regular alcohol consumption per week (units) ✓ –
Neuropsychological
  Center for Epidemiologic Studies Depression Scale (CES-D) score to assess symptoms of depression and mood (score range 
0–60)‡42
✓ ✓ ✓ S
  7-Item Short Version Falls Eficacy Scale-International (FES-I) (score)43 plus three additional FES-I items to assess ‘fear of 
falling’‡44
✓ ✓ ✓ S
  Montreal Cognitive Assessment (MoCA) tool (converted MoCA score) to assess cognitive function (score _/30)‡29 ✓ ✓ ✓ S
 Physical
  Gait speed over 4 m (usual pace)45 and 7 m (usual pace and as fast as possible)46 (best of two trials per measure, m/s) ✓§ ✓ ✓ ✓ S
Continued
 on 26 March 2019 by guest. Protected by copyright. http://bmjopen.bmj.com/ BMJ Open: first published as 10.1136/bmjopen-2018-023526 on 20 March 2019. Downloaded from 
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TS RS MS T1 T2 T3 O
  Hand grip strength using a dynamometer (kg, max score of 3 reps per hand, using the protocol of the InChianti study) ✓ ✓ ✓ –
  Five times sit-to-stand to assess functional strength45 ✓ ✓ S
 Physical—balance
  Able to perform ‘Tandem stance’ for 10 s with eyes open (yes/no) ✓ S
  Community Balance and Mobility Scale (CB&MS) used to measure higher level balance and mobility47 ✓ ✓ ✓ S
  Static balance measured using the 8-Level Balance scale18 ✓ ✓ ✓ S
  Physical—instrumented (participants have a smartphone attached to their lower back, instructions are provided by the assessor. 
Activity is recorded for the duration of the assessment)
  30 s chair stand is completed to quantify strength35 ✓ ✓ ✓ S
  Timed Up and Go33 to measure sit-to-stand duration and movement jerk, mean step time, variability of step time, interstride 
trunk sway in anterior-posterior and mediolateral directions34
✓ ✓ ✓ S
  Tandem stance, 30 s, eyes closed, to assess sway in anterior-posterior and mediolateral directions ✓ ✓ ✓ S
  Five times sit-to-stand to quantify strength and measure sit-to-stand duration ✓ S
  Physical—self-administered (instructions are provided in written form (paper and smartphone) and acoustic cues are provided 
through the smartphone)
  Timed Up and Go33 is completed to measure sit-to-stand duration and movement jerk, mean step time, variability of step time, 
interstride trunk sway in anterior-posterior and mediolateral directions34
✓ ✓ S
  Tandem stance, 15 s, eyes closed, to assess sway in anterior-posterior and mediolateral directions ✓ S
  Tandem stance, 15 s, eyes open, to assess sway in anterior-posterior and mediolateral directions ✓ S
  Five times sit-to-stand to quantify strength and measure sit-to-stand duration ✓ ✓ S
 Physical—sensor-derived data
  Behavioural complexity of PA and sleep measured through activity monitoring (data collection for 7 continuous days) (type, 
duration, intensity)
✓ ✓ ✓ P 
  Physical activity39 (a set of sensor-based features extracted from signals, including the percentages of sedentary, active and 
walking times, duration and intensity (metabolic equivalent) of the activities, and gait and turning characteristics)
✓ ✓ ✓ S
Health economics/quality of life
  EuroQol-5D, EQ-5D-5L to measure quality of life and as a utility-based quality of life instrument will be used for estimating 
QALYs (descriptive proile and a single index value for health-related quality of life)48
✓ ✓ ✓ S
  12-Item Short Form (SF-12) survey to measure function and well-being/quality of life49 ✓ ✓ ✓ S
  A resource-use questionnaire is used to ascertain health resource utilisation (eg, GP visits, medication use and healthcare cost 
from a societal perspective)
✓ ✓ ✓ S
Adherence (monthly follow-up during active and passive intervention period)
  Number of visits/calls successfully completed during the intervention period S
  Withdrawals from intervention (n) S
Table 3 Continued 
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  PreventIT mHealth system use after 6 months (eLiFE only) S
  Uptake and adherence to recommendations/LiFE (all three intervention arms, monthly question) was assessed via email (by 
use of a secure web-based form) or post including one reminder. ‘Over the last seven days, did you perform the recommended 
level of physical activity?’ The response options are as follows: (1) yes, I did more than I planned; (2) yes, I did them all; (3) 
yes, but not as much as I intended; (4) no, I did not feel well; (5) no, I forgot; (6) no, I did not have time; (7) no, I do not like 
these activities. The control group’s response is identical to the options from the active arm, except the generic term ‘physical 
activity’ is used instead of ‘activities’.
S
  Adherence to the recommendations/LiFE (all three intervention arms, at post-test and follow-up) and validation of the monthly 
adherence questions will be evaluated by use of the Exercise Adherence Ratio Scale (EARS)50
✓ ✓ S
Experience, motivation and behavioural change
  Self-Reported Behavioural Automaticity Index to assess habit formation (score, 7-point Likert scale)51 ✓ ✓ S
  Level of ease or dificulty in engaging with the intervention and integrating balance, strength and PA into everyday life (score, 
7-point Likert scale)
✓ ✓
  Motivational aspects of the intervention (score, 7-point Likert scale) ✓ ✓ S
Willingness to participate
  Recruitment numbers, dropouts (n), CONSORT (participant numbers through trial progression)
  Health Action Process Approach (HAPA) to measure participants’ motivation52 ✓ ✓ ✓ S
Usability of technology (eLiFE only)
  The System Usability Scale53 at post-test and 12 months follow-up ✓ ✓ S
  The Telehealthcare Satisfaction Questionnaire–Wearable Technology (TSQ-WT)54 at post-test and 12 months follow-up ✓ ✓ S
  Issues logs from eLiFE participants will be summarised and described
  PreventIT mHealth system feasibility, adherence and progression ✓ ✓ S
  Usability technology (questionnaire) ✓ ✓ S
  Data from PreventIT mHealth system
 Ź PA sensors (daily distribution of walking, sedentary time and active intervals).
 Ź Daily reporting of activities (strength and balance goals achieved?).
 Ź Use of smartphone (number of phone calls, SMS, number of contacts, GPS location (STU and TRD only)).
 Ź Use of application (usage, changes in activity selection).
 Ź Dificulties with technology (via an issue log).
✓ ✓ S
  Acceptability of the intervention ✓ S
  Focus groups (10 participants per intervention arm, at each site): qualitative analysis of narratives of experience of recruitment 
process, randomisation process, screening and assessments, home visits, instructors, tools used (paper-based or technology), 
support in intervention period, activities undertaken, ideas for improvement. Qualitative data will also be used to evaluate 
usability of technology.
✓ S
  Focus groups (with all assessors and instructors): qualitative analysis of narratives of recruitment process, training, successes 
and challenges in delivering intervention, ideas for improvement
✓ S
  Issue logs from the instructors will be evaluated related to acceptability from the instructors’ perspectives. S
Table 3 Continued 
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randomisation platform and forwards the result to the 
instructors who provide the intervention. Recruitment 
continues until 60 participants have completed their first 
home visit per study site.
Interventions
Following the feedback from participants in a pilot study, 
the aLiFE activity framework is applied in both interven-
tion arms. Details of the intervention components are 
shown in table 6 (Template for Intervention Description 
and Replication Guidelines). In short, the programme 
consists of strategies (A) to improve balance by use of four 
principles (‘decreasing base of support’, ‘shifting your 
weight to the limits of stability’, ‘stepping over objects’ 
and ‘stepping, hopping and jumping in different ways’); 
(B) to increase muscle strength by use of seven principles 
(‘bend your knees’, ‘sit to stand’, ‘on your toes’, ‘on 
your heels’, ‘up the stairs’, ‘move sideways’ and ‘tighten 
muscles’); and (C) to reduce sedentariness and increase PA 
by teaching the participants two principles (‘sit less’ and 
‘walk more’). In addition, the programme comprises a 
behavioural change model for developing intentions to 
become more physically active and turning these inten-
tions into actions by embedding activities into daily life 
to make them habitual. As the participants learn the 
programme, they can find opportunities, choose other 
activities and upgrade their existing activities (table 6).
The activities are individually tailored to each partici-
pant’s functional status at the first home visit by use of an 
initial balance and strength assessment (the LiFE assess-
ment tool),17 defining the starting level for the balance and 
strength activities.
Both eLiFE and aLiFE participants receive home visits 
during which instructors teach and deliver the LiFE 
programme. Three follow-up/booster phone calls are 
also provided during the 6-month active intervention 
period (table 6). eLiFE participants receive instructions 
by use of video clips, pictures and text/verbal instruc-
tions in the PreventIT application on a smartphone for 
each activity and aLiFE participants use a paper-based 
manual with descriptions and instructions for the same 
activities. eLiFE participants receive android phones that 
they use during the intervention and follow-up period. 
Participants without any smartphone experience receive 
one extra home visit with information on how to use a 
smartphone prior to starting the home visits in week 1. 
eLiFE participants also receive technological support to 
navigate through the application. The architecture of the 
eLiFE application system is shown in figure 1. The active 
intervention is scheduled for 6 months in order to be able 
to change behaviour.14 36 Participants are encouraged to 
continue independently to use smartphones and smart-
watches (eLiFE) or their paper materials (aLiFE) during 
the passive follow-up period (between months 7 and 12).
eLiFE/aLiFE instructors
The instructors follow an eLiFE and aLiFE instructor 
manual with topics to teach during each home visit/
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phone call. To ensure all clinical sites deliver the 
programme in a standardised manner, instructors 
attended a 3-day workshop covering the eLiFE and aLiFE 
concept. aLiFE components including aims, activity prin-
ciples, behavioural change concept, instructing and 
supporting the participants in action planning using the 
activity planner and activity counter, upgrading activities 
during subsequent home visits and phone calls, and safety 
principles were taught. The eLiFE concept included the 
same content as aLiFE and additionally, knowledge about 
the PreventIT mHealth system and how to instruct the 
participants to use the technology was included in the 
workshop. All instructors were tested and awarded certi-
fication prior to the start of the study, to ensure that they 
had the competences needed to deliver both the eLiFE 
and the aLiFE interventions.
Control group
The control group receives one home visit to provide 
them with a two-page written summary of the WHO 
recommendations of PA.37 These guidelines are relevant 
to all healthy older adults unless specific medical condi-
tions indicate the contrary, and highlight the benefits 
of being physically active as well as stimulate the recom-
mended amount of PA to be undertaken per week.
Focus groups
Semistructured focus group interviews are conducted with 
a maximum of 10 participants from each intervention 
Table 4 Schedule of enrolment, interventions and assessments
Time point
Enrolment
Study period
Preallocation Allocation Postallocation
t
2
t
1
T1 0 PA
1
HV1* T2 PA
2
T3 PA
3
Enrolment
  Telephone screening
  Risk screening
  Medical screening
  Randomisation
  Assessment†
  Baseline
  PA monitoring
  Reassessment
  Follow-up
Intervention (active intervention)
  eLiFE
  aLiFE
  Control group
Intervention (passive intervention)
  eLiFE
  aLiFE
  Control group
PA monitoring/PA
1
, PA
2
, PA
3
 participants’ physical activity was monitored for 7 consecutive days. No contact to the research 
team was permitted during this time.
*Home visit (HV) 1 was completed 8–15 days after the baseline assessment.
†Outcome measures collected during the assessments are listed in table 3.
aLiFE, adapted LiFE; eLiFE, enhanced LiFE; PA, physical activity.
Table 5 Overview of intervention time frame
Time point eLiFE aLiFE
Week 0 Extra home visit if no prior 
smartphone experience
Week 1 Home visit 1 Home visit 1
Week 2 Home visit 2 Home visit 2
Week 4 Phone call 1 Home visit 3
Week 5 Home visit 3 Phone call 1
Week 6 Home visit 4
Week 9 Home visit 4 Home visit 5
Week 11 Phone call 2
Week 13 Phone call 2 Home visit 6
Week 17 Phone call 3 Phone call 3
aLiFE, adapted LiFE; eLiFE, enhanced LiFE.
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 Table 6 Intervention description using the Template for Intervention Description and Replication (TIDieR) checklist
1. Brief name
Study name
PreventIT (Early risk detection and prevention in ageing people by self-administered ICT-supported assessment and a behavioural change intervention, delivered by 
use of smartphones and smartwatches)
Intervention 
groups
The aLiFE programme
(experimental group 1)
The eLiFE programme
(experimental group 2)
WHO guidelines
(control group)
2. Why A rapidly ageing population will place increasing stress on our healthcare systems. The focus needs to shift from treatment towards health promotion for active and healthy 
ageing and prevention of age-related diseases. The PreventIT project has adapted a Lifestyle-integrated Exercise (LiFE) programme (to suit healthy young older adults at risk for 
future accelerated functional decline into two interventions: one delivered by instructors and use of paper manuals (aLiFE), and one delivered via mobile phone (smartphone) with 
a virtual instructor (eLiFE). The aim is to develop and test a personalised behaviour change intervention on physical activity aimed at young older adults that has the potential to 
prevent accelerated functional decline at older age.
3. What materials All participants received a detailed risk and baseline assessment at their respective study sites, assessing medical history, physical and cognitive functions and quality of life. All 
participants had their PA levels recorded for 7 consecutive days using activity monitors. In all three groups, participants completed motivational questionnaires prior to beginning 
the intervention.
Paper manual 
The aLiFE manual included descriptions and instructions of 
the activities selectable within the programme (strength and 
balance exercises), an activity planner (weekly use) and activity 
counter (daily use), safety instructions and further information 
about increasing physical activity and reducing sedentariness.
PreventIT mHealth system on smartphone and smartwatch
eLiFE was delivered via the PreventIT mHealth system. Participants received 
instructions by use of video clips, pictures and text/verbal instructions on the 
PreventIT smartphone for the activities. The architecture of the eLiFE application 
system is shown in igure 1. Activity planning, reporting and feedback is provided 
entirely through the smartphone application. Participants receive one troubleshooting 
document to aid with technological problems they may encounter. Instructors are 
available to help participants use the smartphone during home visits.
One-page WHO 
guidelines regarding 
recommended PA levels 
per week for the target 
group
4. What procedure All participants receive a risk screening and medical assessment to ensure study eligibility and rule out contraindications to an exercise intervention. A detailed baseline 
assessment at a clinical site and a 7-day PA monitoring is completed. Participants are informed of their group allocation after their 7 days of PA monitoring is completed.
Intervention groups
Receive direct support through a trained staff member to implement the aLiFE/eLiFE programme into their daily life and understand the concept of the 
programme. Assistance is provided on how to select, upgrade and identify additional daily situations to integrate activities. Participants receive home 
visits as well as support phone calls during the 6-month active intervention period as part of the ongoing active intervention.
Control group
During a single home 
visit the written WHO 
guidelines are provided 
to participants with 
guidance on the dose–
response relationship 
between the frequency, 
duration, intensity, 
type and total amount 
of physical activity 
recommended per week.
5. Who provided Assessment All assessments completed at the clinical sites are completed by blinded research staff with tertiary qualiication as physiotherapists or exercise scientists. Assessments are 
completed at baseline (T1), 6 months after randomisation (T2) and 12 months after randomisation (T3).
Intervention Following randomisation, participants receive the relevant intervention delivered in their home, provided by physiotherapists or exercise scientists. All staff had undergone a 
3-day workshop to ensure standardised intervention delivery across all three clinical sites.
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1. Brief name
Study name
PreventIT (Early risk detection and prevention in ageing people by self-administered ICT-supported assessment and a behavioural change intervention, delivered by 
use of smartphones and smartwatches)
Intervention 
groups
The aLiFE programme
(experimental group 1)
The eLiFE programme
(experimental group 2)
WHO guidelines
(control group)
6. How Invitation to 
participate
Persons born between 1947 and 1956 (61–70 years of age at the time of inclusion) were invited via mail-out to participate. Three respective local registries randomly selected 
persons within the target group. Participants were required to contact their respective site actively if they were interested.
Telephone screening A telephone screening determined eligibility to attend the risk screening of potential participants.
Risk screening and 
medical screening
The risk screening is completed by trained researchers and a medical screening is completed by medical doctors at each site. The multistep process ensures participants meet 
inclusion/exclusion criteria, and that an exercise programme is deemed safe from a medical perspective.
T1, T2, T3 
assessment
The assessments are completed by blinded research staff at the three clinical sites.
The interventions (aLiFE and eLiFE) are delivered in the 
participants’ home, the types of activities and dificulty levels 
are dependent on the individual’s ability and preference. Home 
visits and follow-up phone calls are completed according to 
a predeined schedule. Participants are permitted to attend 
further exercises groups, undertake other activities or seek 
further healthcare during the duration of the trial which are 
beyond the scope of the RCT. Details are recorded during 
assessments (T2, T3) but no additional assistance is provided 
by the research staff.
The control group receives a single home visit and is provided with written information about PA 
recommendations only.
Participants are permitted to attend exercise groups, undertake other activities or seek healthcare during the 
duration of the trial which are beyond the scope of the control group intervention. Details are recorded during 
assessments (T2, T3) but no additional assistance is provided by the research staff.
7. Where The RCT is conducted as part of the PreventIT project, a European Horizon 2020 ICT and personal health project (project number 689238). The three participating clinical centres 
are Trondheim, Norway; Amsterdam, The Netherlands; and Stuttgart, Germany.
8. When and how 
much
The aLiFE programme
(experimental group 1)
The eLiFE programme
(experimental group 2)
WHO guidelines
(control group)
Home visits, phone 
calls
6 home visits
3 phone calls
4 home visits
3 phone calls
1 home visit
Active intervention 
period
6 months 6 months NA
Passive follow-up 
period
6 months 6 months 12 months
Instructor main role Teach the programme Teach how to use the PreventIT mHealth system NA
Activities Participants choose activities from the strength, balance and/
or PA domain to integrate into their daily activities. The number 
of activities is individual and an activity planner and counter is 
used for documentation purposes.
The PreventIT mHealth system suggests a list of activities to participants ranked 
according to the expected level of beneit. Participants select their preferred activities 
from this list. The number of activities chosen is determined by the individual.
NA
Training goals Decided by the participants with help of a prespeciied list of 
possible goals
Participants select goals from a prespeciied list within the application NA
Phenotyping tool Not used in aLiFE Results from assessments (T1) are included in the PreventIT mHealth system for each 
participant individually prior to the irst home visit to decide what to prioritise among 
the activities (balance, strength or physical activity).
NA
Motivation Provided by the instructor-based individual progress (eg, 
reviewing the activity planner during home visits)
Personalised motivational messages are displayed on the phone based on chosen 
activities and the reported adherence
NA
Social interaction/
chat
NA Participants can use the platform ‘Slack’ for group chat to communicate 
anonymously with other eLiFE participants at their clinical site.
NA
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1. Brief name
Study name
PreventIT (Early risk detection and prevention in ageing people by self-administered ICT-supported assessment and a behavioural change intervention, delivered by 
use of smartphones and smartwatches)
Intervention 
groups
The aLiFE programme
(experimental group 1)
The eLiFE programme
(experimental group 2)
WHO guidelines
(control group)
9. Tailoring aLiFE assessment 
tool (LAT)
The LAT is performed at the irst home visit so the instructor 
can set the initial dificulty level on the balance and strength 
activities.
The LAT is performed at the irst home visit, instructors manually add the results to 
the PreventIT mHealth system and the system sets the initial dificulty level on the 
balance and strength activities.
NA
Progression The instructor teaches the participants when to upgrade the 
number of activities and situations during the subsequent home 
visits
Participants can independently progress their activities based on the rule that the 
user has performed the activity each day for the last 7 days for at least 50% of the 
goal on average and at least 50% of the goal on each of the last 3 days.
The progression is not compulsory when a higher level becomes accessible.
Feedback Feedback is provided by the instructor based on individual 
progress (reviewing the activity planner and counter) during 
home visits.
Participants receive feedback on their PreventIT mHealth system:
1. Based on physical behaviour monitored by the smartphone and the smartwatch 
(time of PA and amount of sedentariness).
2. Depending on the amount (type and dose) of strength and balance activities 
completed (in-app adherence reporting) in relation to the intended type/dose.
NA
10. Modiication Super-user Participants are recommended to select activities that are challenging and relevant to the individual as identiied using the LAT. As some participants 
reached level 4 (highest level) on certain activities (mainly strength exercises), further ‘upgrades’ to the activities were offered. This ‘super-user’ 
concept aims to further increase the task challenge (beyond level 4) in order to ensure a training intensity which induces motor adaptations and 
clinically relevant improvements in functional performances. It includes elements of peak strain, slow motion (extended muscle loading), increased 
number of repetitions, differential training (learning through change/differences in movement variables, eg, joint angle/position), combining strength and 
balance activities, decreasing base of support and more complex sensorimotor tasks.
Participants are able to access the ‘super-user’ function for a speciic activity after having performed the particular activity at 100% for 14 consecutive 
days.
NA
11. How well 
planned
Participant daily 
adherence
Daily adherence can be reported using the activity counters, 
with responses being dichotomous (completed, not completed).
Daily adherence is reported on the PreventIT mHealth system that speciically asks 
about the planned/intended activities as previously deined by the participant.
NA
Participant monthly 
adherence
Monthly adherence data are obtained via a weblink or via a postal question. Participants are asked if they completed all their activities/PA as intended in the last 7 days. The 
responses are: (1) yes, more than intended; (2) yes, as much as intended; (3) yes, but not as much as intended; (4) no, did not feel well; (5) no, forgot; (6) no, no time; (7) no, 
dislike of planned activity.
Instructor idelity Training is delivered independently in each of the three clinical sites. All instructors adhere to a single training protocol to ensure standardised delivery of the programme across 
sites. Training delivery was taught during a 3-day workshop with subsequent exam.
aLiFE, adapted LiFE; eLiFE, enhanced LiFE; ICT, Information and Communication Technology; NA, not applicable (this intervention component is not available in this intervention arm/control group); PA, physical activity; 
RCT, randomised controlled trial; T1, baseline assessment; T2, assessment 6 months after randomisation±2 weeks; T3, assessment 12 months after randomisation±4 weeks.
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arms and control group at each site, after the post-test 
(T2) assessment. The topics to be discussed include: (A) 
the recruitment process; (B) the randomisation process; 
(C) screening and assessments; (D) home visits; (E) the 
instructors; (F) the tools used (paper based and tech-
nology enabled); (G) support in the intervention period; 
(H) the activities undertaken; (I) experience of the 
follow-up period; and (J) ideas for improvement. In addi-
tion, the eLiFE participants are asked to keep an ‘Issues 
log’ to record issues and difficulties with the technology 
and on the trial procedure.
At the end of the trial, interviews with the assessors 
and the instructors will be performed. Interviews will be 
performed face-to-face using a semistructured interview 
guide. Topics to be discussed include: (A) the recruitment 
process; (B) the training received; (C) successes and chal-
lenges in delivering the intervention; and (D) ideas for 
improvement. Focus groups and interviews are expected 
to last between 90 and 120 min. All focus groups and inter-
views are recorded using a digital voice recorder, tran-
scribed and translated into English prior to data analysis.
Participant retention, adherence and dropout
Participants’ progression through the study phases is 
documented and presented in a Consolidated Standards 
of Reporting Trials38 flow diagram. Reasons for dropout 
from the entire trial, or the intervention programme 
only, are recorded. In consenting to the trial, participants 
are consenting to the trial treatment, follow-up and data 
collection. If withdrawal from the randomly allocated 
Figure 1 The architecture of the enhanced LiFE (eLiFE) system. Physical behaviour is continuously monitored by a smartphone 
and a smartwatch, connected through a Bluetooth. The same units are also used for delivering the intervention. Data are 
calculated and stored locally on the smartphone and then sent to a cloud-based server for further processing and storing. The 
collected information is sent back to the smartphones in the form of motivational messages and feedback on behaviour. 
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treatment occurs, participants are still followed up if they 
consent. Participants are allowed to withdraw without 
giving a reason at any time and a withdrawal corticotro-
pin-releasing factor is completed to document the date 
and reason (if known) for withdrawal. Data collected 
up to the time of withdrawal will be included in analyses 
unless the patient specifically asks for it to be withdrawn.
In all three study arms adherence to the intervention is 
measured monthly by use of a single question answerable 
via email or postcard (see details in table 6). The inter-
vention arms also report their exercise adherence on a 
daily basis through in-app reporting (eLiFE) or paper 
documentation (aLiFE: activity counter). Adherence 
measures are part of the study procedure as well as an 
outcome measure in this trial.
safety considerations and adverse events
Based on existing literature, the risk of adverse events 
during the eLiFE and aLiFE training is estimated to be 
low.17 18 The safety aspect is emphasised in the eLiFE and 
aLiFE programmes, including the participants’ manuals 
and smartphone app. Exercise training can have side 
effects and thus some adverse reactions such as muscle 
pain or adverse events like falls due to being more physi-
cally active in everyday life are expected. Several strategies 
have been incorporated in this trial to minimise the risk 
for study participants.
The number and description of adverse events that 
occur during the intervention and follow-up period that 
could be attributable to participation in the eLiFE or aLiFE 
programme are recorded. Participants are encouraged to 
Figure 2 PreventIT low diagram. aLiFE, adapted LiFE; eLiFE, enhanced LiFE.
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report any adverse events and the medical responsible 
person at each site evaluates the need for further medical 
care. In case of any serious adverse event, participants are 
encouraged to seek appropriate medical advice/help. All 
adverse events are reported to the PreventIT Indepen-
dent Data Monitoring Committee and will be reported in 
all publications arising from this project.
Planned data analyses
A complete data analysis plan was finalised on 3 October 
2017 before the T2 assessments (at 6 months) started 
(accessible via first author).
The first analyses will be performed blinded to group 
allocation. It will be evaluated whether there is a pattern 
of missing data, and sensitivity analyses will be performed 
when missing data, collected via an assessor or using the 
smartphone, are judged not missing at random. Data 
at baseline will be analysed using descriptive statistics. 
The primary clinical outcome measures will evaluate the 
change in function from baseline (T1) to follow-up (T3), 
for the eLiFE and the aLiFE interventions compared with 
the control group. Linear mixed models will be used 
which will include factors for time point and study allo-
cation, as well as their interaction, as independent vari-
ables. Within-subject baseline risk will be accounted for 
by including a subject-specific random intercept. Due to 
a limited number of centres (3), the centre effect will be 
treated as fixed rather than random, and included among 
the independent variables. Estimates of effect sizes for the 
differences between eLiFE, aLiFE and control groups, 
and for changes within the eLiFE and aLiFE groups, will 
be provided as mean differences for the outcome vari-
ables. In case of non-normality, other appropriate models 
will be used. Results will be used to perform calculations 
of sample sizes to determine the optimal number of 
participants to be included when planning for a future 
final RCT to detect a real effect as statistically significant.
The analysis of change will be based on intention to 
treat, but a per-protocol analysis will also be conducted 
as a sensitivity analysis as this is likely to provide further 
insight into the feasibility of the interventions.
In order to determine a potential dose–response asso-
ciation between the adherence and outcome, the associa-
tion between the two primary clinical outcomes, measured 
by LLFDI and activity monitoring (complexity metric), 
and the adherence measures collected (single question 
every 4 weeks to all participants in all three groups) will be 
assessed. Further subgroup analysis dependent on group 
allocation or adherence is described in detail in the anal-
ysis plan.
Multimodal analyses will be performed to calculate 
behavioural complexity using appropriate metrics such 
as Lempel-Ziv complexity (LZC). LZC determines the 
number of distinct temporal sequences of multivariate PA 
states, as well as the rate of their recurrence, with larger 
values indicating higher complexity of the given activity 
pattern.20 Data collected from the 7-day activity moni-
toring will be processed offline making use of software 
developed in the FARSEEING project (http:// farseein-
gresearch. eu).39 A set of sensor-based PA features will be 
extracted from the signals, including the percentages of 
sedentary, active and walking times, duration and inten-
sity (metabolic equivalent) of the activities and gait and 
turning characteristics. Combinations of these features 
will be used to define the multivariate states.20
A further focus of the analyses will be on the willingness 
to participate, adherence to the interventions and accep-
tance of the interventions, including the technology used 
to deliver the intervention and give feedback and motiva-
tion for behavioural change.
Another focus will be to analyse the data collected by 
the technology to establish their reliability, to analyse 
participants’ perception of which activities they have 
completed compared with what sensors have recorded as 
well as exploring additional metrics.
The health economics analysis will focus on the feasi-
bility of collecting data on, and estimate, healthcare 
resource utilisation, costs and QALYs, and model ICER 
of eLiFE and aLiFE compared with the control group 
over a 6-month and 12-month period in a standard with-
in-trial evaluation model. EQ-5D-5L health utility scores 
will be used to calculate QALYs for economic evaluation. 
Published national unit costs will be used to calculate the 
total costs of resource utilisation.
This feasibility RCT is a hypothesis-generating study, 
where additional explorative analyses not described in 
this protocol paper or data analysis plan might be planned 
and performed.
data storing and security
Data are collected by the research staff, and from 
smartphones and smartwatches used by eLiFE partici-
pants. Data are stored in three different locations: in a 
web-based case report system (WebCRF), developed by 
NTNU, in the memories of the individual smartphones 
and in an in-house protected server at NTNU. Data are 
synched daily from the smartphones onto the servers. 
Moreover, data on the servers are backed up daily as part 
of the routine scheduled backup of the NTNU computer 
centre that hosts the PreventIT servers. Participants’ ID 
and identifiable information are kept locally and securely 
by recruiters at each site at all times. Data in the WebCRF 
and in the NTNU servers are pseudonymised. Only 
research staff directly involved in the analysis of the RCT 
will have access to the final trial data set, which will only 
contain non-identifiable information.
The in-house web server will be in a demilitarised zone 
and behind a firewall. Both the WebCRF and the data 
servers will be behind a second firewall. Security and 
other ethical issues are priority, as sensor systems that 
monitor and report on health-related behaviours depend 
on the processing of personal data. All the data on the 
server are maintained in encrypted databases.
All data on smartphones are kept in encrypted data-
bases. All transmission of data between the server and the 
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smartphones is encrypted. Each phone/user is provided 
with an individual user login.
After the conclusion of the feasibility RCT, data will 
remain stored on the NTNU server in pseudonymised 
format using participant IDs. Coupling to personal IDs 
will be stored securely for 5 years after the end of the 
PreventIT project at each of the three sites. After this, 
data will be fully anonymised.
Participant and public involvement
Prior to commencing this feasibility RCT, pilot studies 
were conducted for both the eLiFE and the aLiFE inter-
vention modes. These pilot studies provided information 
about the practical execution of collecting the relevant 
outcome measures, and to improve the intervention 
components, with a focus on the feasibility and accept-
ability of the balance, strength and PA activities. The 
eLiFE intervention was further tested for usability and 
acceptability within the target group. Focus groups were 
conducted during the pilot studies, providing insight 
into participants’ priorities, experience and preferences. 
There are no participant advisers in the study, as the aim 
is to conduct a feasibility RCT and not a final RCT.
Following the participants’ final assessment (T3), all 
participants will get individual, written results from their 
participation providing them with an overview of the 
study status and their personal results regarding phys-
ical outcome measures and the 7-day consecutive PA 
monitoring.
In total, 7500 persons between 61 and 70 years of age were 
drawn from the local registries in Norway, Germany and 
the Netherlands. Two thousand letters in Trondheim, 1500 
letters in Stuttgart and 4000 letters in Amsterdam were sent. 
Following the three-step screening process, 180 participants 
were successfully enrolled into the study, accepted rando-
misation and completed their first home visit. The flow of 
participants from recruitment until randomisation is shown 
in figure 2.
dIsCussIon
The current study is designed to evaluate the feasibility of 
conducting an RCT of a lifestyle-integrated intervention 
delivered in two modes, aLiFE (an instructor-delivered, 
paper-based intervention) and eLiFE (a newly developed 
intervention using a mobile health application system) 
compared with simply being given guidelines on PA 
requirements. Both interventions entail embedding activ-
ities into daily life, strengthened by a behavioural change 
model aimed at making the activities habitual. This study 
further develops and adapts the LiFE programme to suit 
a younger population of seniors, at retirement age (61–70 
years). Particularly at time of retirement, LiFE-based 
interventions may be beneficial to young older adults by 
specifically completing lower extremity muscle strength-
ening and balance activities as well as increasing PA to 
avoid later age-related functional decline. In compar-
ison to traditional exercise programmes, such as group 
training and gym workouts where one needs to set aside 
dedicated time to follow the programme, LiFE-based 
programmes embed small bouts of activities into the 
individual’s routines that are already part of their daily 
life. This individual tailoring of exercises, and embed-
ding them into daily routines, seems to be a promising 
approach to keep young older adults active.40
Capitalising on the benefits of technological advances 
and embedding the concept into a mobile health appli-
cation system, aLiFE was transferred to an ICT platform 
to create eLiFE using smartphones and smartwatches, 
commonly available technology already in use in this 
target population. There is a rapid development in mobile 
health application technology, with numerous health 
applications currently available. Application systems may 
motivate persons to be more physically active, provide 
opportunities to personalise interventions, provide feed-
back to the person using the technology and help people 
keep track of their PAs. Despite this potential, there is 
at present a lack of systems developed based on existing 
knowledge from research on exercise programmes and 
behavioural change, and tailored for use in young older 
(61–70 years) adults. The current trial will provide data 
on feasibility and usability of both the mobile health 
application in eLiFE and the instructor-delivered aLiFE. 
The aim is that the interventions can empower this popu-
lation to maintain or increase their activity levels, so that 
they can stay active and healthy longer at advancing age. 
The study will provide more knowledge about how to 
integrate demanding activities into daily life and how to 
deliver an intervention to young older adults in order to 
increase their daily PA.
Finally, it is challenging to recruit a target population 
of young older adults without current signs of functional 
decline. Understanding how to recruit this specific popu-
lation will aid in providing recommendations for a future 
RCT.
ConCLusIons
It is expected that both eLiFE and aLiFE have the potential 
to provide effective means to increase PA and complexity, 
improve functional capacity and change behaviour in 
young older adults. By using technology in eLiFE, it is 
expected that the behavioural change aspects of the 
aLiFE intervention are strengthened. It is also expected 
that an intervention that embeds more activity into daily 
life has the potential to empower young older adults to 
stay active at older age and therefore has the potential to 
reduce the risk of future functional decline.
Ethics and dissemination
The study has approvals to send invitation letters based 
on data from local/national registries.
We will seek to publish all results from the feasibility trial 
in open-access, peer-reviewed international journals, and 
disseminated at scientific and non-scientific conferences 
and events. Main results will also be shared on the project 
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website and spread to various stakeholders. Authorship 
eligibility will follow the International Committee of 
Medical Journal Editors (http://www. icmje. org/ recom-
mendations/ browse/ roles- and- responsibilities/ defining- 
the- role- of- authors- and- contributors. html).
trial status
The trial commenced recruitment in March 2017. In 
August 2017, a total of 180 participants were included in 
the trial.
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